Anteilseigner
Bain Capital Life Sciences LP (10,29 %) Invus Public Equities Advisors LLC (9,37 %) Adage Capital Management LP (7,75 %) Samsara Biocapital LLC (6,68 %) Avidity Partners Management LP (6,26 %) Point72 Asset Management LP (5,51 %) CHI Advisors LLC (4,86 %) Flagship Pioneering (4,84 %) The Vanguard Group, Inc. (3,46 %) Deep Track Capital LP (3,10 %) Opaleye Management, Inc. (2,95 %) Goldman Sachs & Co. LLC (Private Banking) (1,67 %) Kennedy Capital Management LLC (1,51 %) Blue Owl Healthcare Opportunities Advisors LLC (1,28 %) Walleye Capital LLC (1,07 %) Millennium Management LLC (0,98 %) Omega Fund Management LLC (0,94 %) BlackRock Fund Advisors (0,94 %) Ally Bridge Group HK Ltd (0,93 %) David M. Knott Partnership (0,87 %)
Kontakt
Syros Pharmaceuticals Inc.